Antibody-dye Conjugates – A Targeted Light Activated Anti-Cancer Treatment

Antibody-dye Conjugates – A Targeted Light Activated Anti-Cancer Treatment

0 0 3 months ago
In this episode of The Onco’Zine Brief Peter Hofland talks with Peggy Berry, Vice president of Global Regulatory Affairs at Rakuten Medical.*

Rakuten Medical is developing a technology platform called Illuminox™ which is based on a cancer therapy called Near Infrared Photoimmunotherapy. This technology was originally developed by Hisataka Kobayashi, M.D., Ph.D. and his team at the National Cancer Institute (NCI) in the United States. [1]

Rakuten Medical’s first investigational drug, based ... See More

Find us on Facebook